ArticleTransactions of the American Ophthalmological Society2013

Cost-effectiveness of bevacizumab and ranibizumab for newly diagnosed neovascular macular degeneration (an American Ophthalmological Society thesis).

Joshua D Stein et al.PubMed ↗Full text ↗

No numbers read from the abstract.